Blood to plasma ratio of mefloquine: interpretation and pharmacokinetic implications.
AI Summary
Key Findings
Abstract
The blood to plasma ratio of the antimalarial mefloquine has been reported to be close to 1, while other reports indicate extensive accumulation in erythrocytes. This apparent contradiction has been resolved by a quantitative examination of the compensating effects of plasma protein binding of mefloquine which almost exactly matches the extent of mefloquine accumulation in erythrocytes. The observed blood to plasma ratio of about 1 arises as the result of a balance between extensive red cell uptake and extensive plasma protein binding. Some pharmacokinetic implications of the distribution of mefloquine within blood are outlined.
Affiliation
Department of Pharmaceutics, College of Pharmacy, Tehran University, Iran.
External References
- PubMed ID:
- 8427948
Comments
Sign in or create a free account to join the conversation.
Sign in to commentBe the first to comment.